Calmerry vs Regeneron Pharmaceuticals
Side-by-side comparison of AI visibility scores, market position, and capabilities
Subscription online therapy via text, video, and audio; accessible pricing for patients managing anxiety and depression; therapist matching with easy switching based on preference selection.
About
Calmerry is an online therapy platform that connects individuals with licensed therapists for mental health support through a subscription model covering text messaging, live video sessions, and audio calls. The platform focuses on accessibility and affordability, offering therapy to users who face barriers of cost, stigma, or geographic access to traditional in-person care. Calmerry matches clients to therapists based on their presenting concerns, preferences, and therapist specialization, with the ability to switch therapists if the initial match is not a good fit. The platform serves a primarily direct-to-consumer audience, individuals managing anxiety, depression, relationship issues, stress, and other mental health concerns. Calmerry competes with BetterHelp and Talkspace in the online therapy market, differentiating through competitive pricing and a straightforward subscription structure. The company has grown rapidly as awareness of teletherapy has expanded following the COVID-19 pandemic, which accelerated consumer acceptance of remote mental healthcare.
Regeneron (REGN) reported $13.9B revenue in FY2024, up 7% YoY. Top biotech company. Dupixent franchise >$14B. Leaders in eye disease, immunology, oncology. HQ: Tarrytown, NY.
About
Regeneron Pharmaceuticals, Inc. is a leading biotechnology company specializing in the discovery, development, and commercialization of medicines for serious diseases, headquartered in Tarrytown, New York. Founded in 1988 by Leonard Schleifer and George Yancopoulos, Regeneron developed its own proprietary drug discovery technology platform (VelociGene, VelocImmune) that has enabled the development of multiple breakthrough medicines. The company reported revenues of $13.9B in FY2024, up 7% year-over-year.
AI Visibility Head-to-Head
Key Details
Capabilities & Ecosystem
Capabilities
Integrations
Also Compare
Track AI Visibility in Real Time
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.